Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2025-12-25 @ 4:48 AM
NCT ID:
NCT01446718
Eligibility Criteria:
Inclusion Criteria:
* HIV-infected
* age 9-14 years
* guardian/parental consent
Exclusion Criteria:
Participants will be excluded if they
* are severely ill as defined by Karnofsky \<70
* have a diagnosis of malignancy
* on-going febrile illness (temperature ≥37.8°C), including active treatment for an opportunistic infection
* have received systemic corticosteroids within prior one year
* have received inactivated vaccine within prior 2 weeks, or live attenuated vaccine within prior 6 weeks
* have history of allergy to any products included in the HPV vaccine
* have received any of blood derivatives within prior 6 months
* are pregnant
* lack parental consent and/or parent declines to provide assent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
9 Years
Maximum Age:
14 Years
Study:
NCT01446718
Study Brief:
Protocol Section:
NCT01446718